NCT02296138 · Interventional trial
Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.
Overall registry status Completed
Phase 3
Conditions Pulmonary Disease, Chronic Obstructive
Delaware Valley sites
- 1237.19.10003 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
- 1237.19.10019 Boehringer Ingelheim Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory